Inflammation and bony changes at the temporomandibular joint

Melissa Kacena, Greg A. Merrel, Sanjit R. Konda, Kimberly M. Wilson, Yougen Xi, Mark C. Horowitz

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Cytokines help mediate the acute and chronic inflammation and associated destruction of connective tissue in arthritic temporomandibular joints (TMJ). The proinflammatory cytokines TNFα, IL-1β, IL-6, IL-8, and IFN-γ are associated with inflammation in synovial joints and connective tissue destruction. Therefore, the increased levels of these cytokines in the synovial fluid of temporomandibular disorder (TMD) patients would be expected. Conversely, IL-1ra and IL-10 acts as inhibitors to these proinflammatory cytokines. Thus, in TMD patients, low levels of IL-1ra and IL-10 might be expected. A review of studies from multiple investigators confirms that proinflammatory cytokine levels increase in TMD patients, IL-1ra levels are also increased, and IL-10 levels remain unchanged. Because IL-10 can inhibit TNFα, IL-1, IL-6, and IL-8, the lack of IL-10 in the TMJ in the face of the other studies showing increases in TNFα, IL-1β, IL-6, and IL-8 could partially explain the exacerbation of the associated osteoarthritis. In addition, although IL-1ra levels are elevated in most of the TMD patients, the increases do not appear to be sufficient to inhibit the inflammation and connective tissue degradation associated with IL-1β. Thus, it appears that treatment of TMD requires a delicate balance between proinflammatory cytokines and cytokine inhibitors such as IL-1ra and IL-10.

Original languageEnglish (US)
Pages (from-to)257-264
Number of pages8
JournalCells Tissues Organs
Volume169
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Temporomandibular Joint
Interleukin 1 Receptor Antagonist Protein
Temporomandibular Joint Disorders
Interleukin-10
Cytokines
Inflammation
Interleukin-1
Interleukin-8
Connective Tissue
Interleukin-6
Synovial Fluid
Osteoarthritis
Arthritis
Joints
Research Personnel

Keywords

  • Bone degradation
  • Cytokines
  • Inflammation
  • Temporomandibular joint
  • Temporomandibular joint disorder

ASJC Scopus subject areas

  • Anatomy

Cite this

Kacena, M., Merrel, G. A., Konda, S. R., Wilson, K. M., Xi, Y., & Horowitz, M. C. (2001). Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs, 169(3), 257-264. https://doi.org/10.1159/000047889

Inflammation and bony changes at the temporomandibular joint. / Kacena, Melissa; Merrel, Greg A.; Konda, Sanjit R.; Wilson, Kimberly M.; Xi, Yougen; Horowitz, Mark C.

In: Cells Tissues Organs, Vol. 169, No. 3, 2001, p. 257-264.

Research output: Contribution to journalArticle

Kacena, M, Merrel, GA, Konda, SR, Wilson, KM, Xi, Y & Horowitz, MC 2001, 'Inflammation and bony changes at the temporomandibular joint', Cells Tissues Organs, vol. 169, no. 3, pp. 257-264. https://doi.org/10.1159/000047889
Kacena, Melissa ; Merrel, Greg A. ; Konda, Sanjit R. ; Wilson, Kimberly M. ; Xi, Yougen ; Horowitz, Mark C. / Inflammation and bony changes at the temporomandibular joint. In: Cells Tissues Organs. 2001 ; Vol. 169, No. 3. pp. 257-264.
@article{0450fa37dd874da89a477064f4f07b14,
title = "Inflammation and bony changes at the temporomandibular joint",
abstract = "Cytokines help mediate the acute and chronic inflammation and associated destruction of connective tissue in arthritic temporomandibular joints (TMJ). The proinflammatory cytokines TNFα, IL-1β, IL-6, IL-8, and IFN-γ are associated with inflammation in synovial joints and connective tissue destruction. Therefore, the increased levels of these cytokines in the synovial fluid of temporomandibular disorder (TMD) patients would be expected. Conversely, IL-1ra and IL-10 acts as inhibitors to these proinflammatory cytokines. Thus, in TMD patients, low levels of IL-1ra and IL-10 might be expected. A review of studies from multiple investigators confirms that proinflammatory cytokine levels increase in TMD patients, IL-1ra levels are also increased, and IL-10 levels remain unchanged. Because IL-10 can inhibit TNFα, IL-1, IL-6, and IL-8, the lack of IL-10 in the TMJ in the face of the other studies showing increases in TNFα, IL-1β, IL-6, and IL-8 could partially explain the exacerbation of the associated osteoarthritis. In addition, although IL-1ra levels are elevated in most of the TMD patients, the increases do not appear to be sufficient to inhibit the inflammation and connective tissue degradation associated with IL-1β. Thus, it appears that treatment of TMD requires a delicate balance between proinflammatory cytokines and cytokine inhibitors such as IL-1ra and IL-10.",
keywords = "Bone degradation, Cytokines, Inflammation, Temporomandibular joint, Temporomandibular joint disorder",
author = "Melissa Kacena and Merrel, {Greg A.} and Konda, {Sanjit R.} and Wilson, {Kimberly M.} and Yougen Xi and Horowitz, {Mark C.}",
year = "2001",
doi = "10.1159/000047889",
language = "English (US)",
volume = "169",
pages = "257--264",
journal = "Cells Tissues Organs",
issn = "1422-6405",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Inflammation and bony changes at the temporomandibular joint

AU - Kacena, Melissa

AU - Merrel, Greg A.

AU - Konda, Sanjit R.

AU - Wilson, Kimberly M.

AU - Xi, Yougen

AU - Horowitz, Mark C.

PY - 2001

Y1 - 2001

N2 - Cytokines help mediate the acute and chronic inflammation and associated destruction of connective tissue in arthritic temporomandibular joints (TMJ). The proinflammatory cytokines TNFα, IL-1β, IL-6, IL-8, and IFN-γ are associated with inflammation in synovial joints and connective tissue destruction. Therefore, the increased levels of these cytokines in the synovial fluid of temporomandibular disorder (TMD) patients would be expected. Conversely, IL-1ra and IL-10 acts as inhibitors to these proinflammatory cytokines. Thus, in TMD patients, low levels of IL-1ra and IL-10 might be expected. A review of studies from multiple investigators confirms that proinflammatory cytokine levels increase in TMD patients, IL-1ra levels are also increased, and IL-10 levels remain unchanged. Because IL-10 can inhibit TNFα, IL-1, IL-6, and IL-8, the lack of IL-10 in the TMJ in the face of the other studies showing increases in TNFα, IL-1β, IL-6, and IL-8 could partially explain the exacerbation of the associated osteoarthritis. In addition, although IL-1ra levels are elevated in most of the TMD patients, the increases do not appear to be sufficient to inhibit the inflammation and connective tissue degradation associated with IL-1β. Thus, it appears that treatment of TMD requires a delicate balance between proinflammatory cytokines and cytokine inhibitors such as IL-1ra and IL-10.

AB - Cytokines help mediate the acute and chronic inflammation and associated destruction of connective tissue in arthritic temporomandibular joints (TMJ). The proinflammatory cytokines TNFα, IL-1β, IL-6, IL-8, and IFN-γ are associated with inflammation in synovial joints and connective tissue destruction. Therefore, the increased levels of these cytokines in the synovial fluid of temporomandibular disorder (TMD) patients would be expected. Conversely, IL-1ra and IL-10 acts as inhibitors to these proinflammatory cytokines. Thus, in TMD patients, low levels of IL-1ra and IL-10 might be expected. A review of studies from multiple investigators confirms that proinflammatory cytokine levels increase in TMD patients, IL-1ra levels are also increased, and IL-10 levels remain unchanged. Because IL-10 can inhibit TNFα, IL-1, IL-6, and IL-8, the lack of IL-10 in the TMJ in the face of the other studies showing increases in TNFα, IL-1β, IL-6, and IL-8 could partially explain the exacerbation of the associated osteoarthritis. In addition, although IL-1ra levels are elevated in most of the TMD patients, the increases do not appear to be sufficient to inhibit the inflammation and connective tissue degradation associated with IL-1β. Thus, it appears that treatment of TMD requires a delicate balance between proinflammatory cytokines and cytokine inhibitors such as IL-1ra and IL-10.

KW - Bone degradation

KW - Cytokines

KW - Inflammation

KW - Temporomandibular joint

KW - Temporomandibular joint disorder

UR - http://www.scopus.com/inward/record.url?scp=0034948185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034948185&partnerID=8YFLogxK

U2 - 10.1159/000047889

DO - 10.1159/000047889

M3 - Article

C2 - 11455121

AN - SCOPUS:0034948185

VL - 169

SP - 257

EP - 264

JO - Cells Tissues Organs

JF - Cells Tissues Organs

SN - 1422-6405

IS - 3

ER -